Artificial wisdom in gastrointestinal diagnostics: A new frontier in translational reasoning

Abstract

Artificial Wisdom represents a paradigm shift in AI-augmented clinical reasoning, integrating historical diagnostic expertise with real-time data, causal inference, uncertainty quantification, and patient-centered decision-making. In gastrointestinal (GI) diagnostics-particularly endoscopy-this approach transcends task-specific pattern recognition to support comprehensive, guideline-aligned decisions about lesion characterization, sampling, and therapy. This mini-review synthesizes the conceptual foundations of Artificial Wisdom and its translational potential in GI endoscopy, highlighting multimodal data integration, causal reasoning, and calibrated uncertainty as pillars of intelligent decision support. We examine current capabilities and limitations of AI systems, propose a three-tier architecture for translational reasoning, and present case-based applications across colorectal polyp management, inflammatory bowel disease surveillance, Barrett’s esophagus, and pancreaticobiliary diagnostics. Implementation challenges-including bias, workflow integration, and regulatory pathways-are discussed alongside research priorities for causally-informed artificial intelligence (AI), human-AI collaboration, and prospective validation. Endoscopy emerges as a proving ground for Artificial Wisdom, offering a pathway to more consistent, equitable, and personalized GI care.

Key Words: Artificial intelligence; Machine learning; Gastrointestinal endoscopy; Computer-aided detection; Polyp detection; Colonoscopy

Core Tip: Artificial Wisdom represents a paradigm shift in artificial intelligence-augmented gastrointestinal (GI) diagnostics, moving beyond narrow task-specific algorithms toward integrated, patient-centered reasoning. By combining multimodal data inputs, causal inference, calibrated uncertainty, and guideline-aligned decision support, Artificial Wisdom frameworks offer a more holistic and clinically meaningful approach to endoscopic decision-making. This mini-review outlines the conceptual foundations, architectural design, and translational applications of Artificial Wisdom in GI endoscopy, highlighting its potential to enhance diagnostic accuracy, equity, and workflow integration.

INTRODUCTION

The concept of “Artificial Wisdom” represents an evolution beyond traditional artificial intelligence (AI) applications in medicine, emphasizing the integration of pattern recognition with causal reasoning, uncertainty quantification, and guideline-concordant decision support across multimodal data sources[1,2]. Unlike narrow AI systems that optimize performance for specific tasks, Artificial Wisdom emphasizes seamless integration with historical domain knowledge, patient context, and longitudinal outcomes to support translational clinical decisions[3,4].

Gastrointestinal (GI) diagnostics, particularly endoscopy, occupies a unique position in this paradigm as a real-time, decision-critical modality where clinicians make rapid determinations about lesion characterization, biopsy protocols, resection techniques, surveillance intervals, and specialist referrals within minutes of visual assessment[5-7]. Historical GI diagnostics have traditionally relied on expert interpretation of mucosal patterns, systematic histopathological correlation, and adherence to evidence-based guidelines for polyp management, inflammatory bowel disease (IBD) surveillance, and pancreaticobiliary lesion assessment[8-10].

Current AI applications in GI endoscopy demonstrate impressive accuracy in isolated tasks such as polyp detection, adenoma characterization, and dysplasia recognition[11-13]. However, translational gaps persist when these systems operate without embedding broader clinical logic, causal inference capabilities, or integration with longitudinal patient data[14]. The challenge lies not merely in achieving high sensitivity and specificity for individual tasks, but in developing systems that can reason across temporal sequences, integrate heterogeneous data sources, communicate uncertainty effectively, and align recommendations with both guidelines and patient-specific factors[15-17].

HISTORICAL EVOLUTION OF GI ENDOSCOPY: FROM VISUAL PATTERN RECOGNITION TO AI INTEGRATION

Pre-digital era foundations

Early endoscopic practice relied entirely on real-time visual interpretation by skilled operators, with diagnostic accuracy heavily dependent on individual expertise and experience[18,19]. The introduction of fiber-optic technology revolutionized GI visualization, enabling systematic mucosal assessment and targeted biopsy protocols. However, inter-observer variability remained significant, particularly for subtle lesions and inflammatory conditions.

Technological milestones and diagnostic evolution

The progression from standard white-light endoscopy to high-definition imaging, narrow-band imaging, chromoendoscopy, and magnification endoscopy has dramatically enhanced diagnostic capabilities[20-22]. Each technological advance required development of new classification systems and training protocols, creating a rich foundation of structured visual interpretation that modern AI systems can leverage.

Confocal laser endomicroscopy and endoscopic ultrasound (EUS) further expanded the diagnostic armamentarium, providing cellular-level and subsurface tissue characterization capabilities[23,24]. These advanced imaging modalities generate complex, multidimensional datasets that challenge human cognitive processing but represent ideal targets for AI-assisted interpretation[25,26].

The translational challenge

Despite these technological advances, significant gaps persist between diagnostic capability and clinical implementation[27,28]. Studies consistently demonstrate wide variation in polyp detection rates, characterization accuracy, and adherence to surveillance guidelines among endoscopists[29]. These variations reflect not only differences in technical skill but also challenges in integrating complex visual information with patient-specific factors and evolving evidence-based recommendations[30,31].

CONCEPTUAL FRAMEWORK: FROM AI TO ARTIFICIAL WISDOM IN GI ENDOSCOPY

Multimodal data integration and architecture

Modern endoscopic AI systems must transcend single-modality approaches to incorporate clinical history, prior imaging studies, histopathological results, serological markers, and treatment responses into coherent decision-support frameworks[32-34]. We propose a three-tier architecture comprising: (1) A perception layer for real-time image analysis and feature extraction; (2) A reasoning layer that incorporates causal relationships and probabilistic inference using domain knowledge and clinical guidelines; and (3) A presentation layer that communicates uncertainty, provides explanations, and generates actionable recommendations[35,36].

This architectural approach enables integration of high-dimensional endoscopic imagery with structured clinical data, creating richer contexts for decision support than either modality alone[37]. For instance, polyp characterization systems can incorporate patient age, family history, prior polyp burden, and histological outcomes to provide more nuanced risk stratification than visual features alone[38].

Causal reasoning and uncertainty quantification

Traditional machine learning approaches in endoscopy focus on correlation-based pattern recognition, potentially missing causal relationships essential for clinical reasoning[39,40]. Artificial Wisdom frameworks must incorporate mechanistic understanding of lesion biology, disease progression pathways, and treatment response mechanisms to provide robust decision support.

Calibrated uncertainty quantification becomes critical when endoscopists must make immediate decisions about biopsy vs resection, surveillance intervals, or referral pathways. Systems must communicate not only predictions but also confidence levels that reflect both model uncertainty and inherent biological variability. This enables shared decision-making where clinicians can appropriately weight AI recommendations against clinical judgment and patient preferences[41,42].

Guideline alignment and patient-centered translation

Effective Artificial Wisdom systems must ensure recommendations align with current evidence-based guidelines while adapting to individual patient contexts[43,44]. In endoscopy, this includes adherence to polypectomy technique recommendations, surveillance interval guidelines, IBD endoscopic scoring systems, and pancreaticobiliary sampling protocols[45-47]. However, rigid guideline adherence without considering patient comorbidities, preferences, and social determinants of health may lead to suboptimal outcomes[48,49].

The translational reasoning component must therefore balance guideline concordance with personalized care considerations, explicitly documenting when and why deviations from standard protocols may be appropriate[50]. This requires sophisticated understanding of clinical workflows, patient values, and healthcare system constraints[51]. Figure 1 summarizes the key differences between artificial wisdom and artificial intelligence.

Figure 1 Comparison of narrow artificial intelligence systems and artificial wisdom frameworks in gastrointestinal endoscopy. This table outlines key differences across ten dimensions relevant to clinical application. Narrow artificial intelligence (AI) systems are characterized by task-specific pattern recognition, single-modality data input, and opaque reasoning, often lacking integration with clinical workflows or patient context. In contrast, Artificial Wisdom frameworks emphasize multimodal data synthesis, causal reasoning aligned with clinical guidelines, calibrated uncertainty, and patient-centered decision support. They also prioritize transparency, equity, regulatory compliance, and outcome utility, reflecting a more holistic and clinically integrated approach to AI in gastrointestinal endoscopy. AI: Artificial intelligence; GI: Gastrointestinal.

AI AS TRANSLATIONAL AMPLIFIER IN ENDOSCOPY: CURRENT CAPABILITIES AND FUTURE DIRECTIONS

Real-time detection and characterization systems

Contemporary AI applications in endoscopy have achieved remarkable success in polyp detection, with several systems demonstrating sensitivity improvements of 10%-15% over unassisted endoscopy[52-54]. Computer-aided detection systems now provide real-time alerts for potential lesions, while computer-aided diagnosis systems offer characterization support for optical biopsy decisions[55].

In IBD, AI systems have shown promise for automated endoscopic scoring, potentially reducing inter-observer variability in mucosal healing assessment[56,57]. Barrett’s esophagus surveillance has benefited from AI-assisted dysplasia detection, with some systems achieving expert-level performance in identifying high-grade dysplasia and early neoplasia[58,59].

Workflow integration and clinical decision support

Beyond detection and characterization, emerging AI systems address workflow optimization through automated report generation, quality metric assessment, and procedure documentation. These applications reduce administrative burden while improving consistency and completeness of endoscopic reporting[60,61].

Advanced decision support systems integrate endoscopic findings with clinical data to recommend biopsy protocols, suggest surveillance intervals, and identify patients requiring subspecialty referral[62,63]. However, most current systems operate as isolated tools rather than integrated components of comprehensive care pathways[64,65].

Limitations and challenges

Several significant limitations constrain current AI applications in endoscopy. Dataset bias remains problematic, with most training datasets derived from high-volume academic centers potentially limiting generalizability to community practice settings[66,67]. Automation bias represents another concern, as clinicians may over-rely on AI recommendations without maintaining appropriate skepticism.

Distribution shifts pose significant challenges when AI systems encounter new endoscopic platforms, imaging protocols, or patient populations not represented in training data[68,69]. Performance degradation under these conditions can be substantial, potentially compromising patient safety[70,71].

Explainability gaps remain a critical barrier to clinical adoption, as many high-performing models provide predictions without interpretable rationale that clinicians can evaluate and trust[72]. This “black box” problem is particularly concerning in high-stakes clinical decisions where understanding the reasoning behind recommendations is crucial[73]. One of the most significant obstacles to the clinical adoption of AI is the lack of explainability. Many high-performing predictions lack a clear rationale that clinicians can comprehend and assess.

CASE-BASED SYNTHESIS: ARTIFICIAL WISDOM IN CLINICAL PRACTICE

Colorectal polyp management

Consider a 65-year-old patient undergoing screening colonoscopy with a 6 mm pedunculated polyp in the sigmoid colon. An Artificial Wisdom system would integrate visual features (polyp morphology, surface pattern, vascular architecture) with patient factors (age, family history, prior polyp history) and current guidelines to provide comprehensive management recommendations[74,75]. The system might recognize high-confidence adenomatous features suggesting cold snare polypectomy, while simultaneously calculating personalized surveillance interval recommendations based on the patient’s overall polyp burden and risk factors[76,77]. Importantly, the system would communicate uncertainty levels, enabling the endoscopist to make informed decisions about immediate management and follow-up planning. Figure 2 suggests an application pathway illustrating the above discussion.

Figure 2 Artificial wisdom-enabled decision pathway for colorectal polyp management. A layered framework integrating real-time endoscopic perception, patient-specific historical data, probabilistic reasoning, and clinician-facing recommendations to guide polyp management. The pathway incorporates morphology classification (Paris), surface pattern analysis (NICE, JNET), and vascular architecture assessment, alongside contextual factors such as prior polyp burden and surveillance history. Outputs include resection technique guidance, referral and tattooing recommendations, and surveillance interval suggestions, culminating in a structured endoscopy report. SSL: Sessile serrated lesion.

IBD surveillance

In IBD surveillance, Artificial Wisdom systems could transform current practice by integrating endoscopic mucosal appearance with histological inflammation, biomarker trends, and patient-reported outcomes[78,79]. For a patient with ulcerative colitis undergoing surveillance colonoscopy, the system could provide real-time mucosal healing scores while identifying subtle dysplastic changes that might escape visual detection. Similar scenario for a Crohn’s disease patient undergoing small bowel assessment through a capsule endoscopy[80]. The integration of endoscopic findings with serological markers, fecal biomarkers, and treatment history would enable more nuanced decisions about therapy escalation or de-escalation[81,82]. This holistic approach could reduce the discordance between endoscopic appearance and histological inflammation that frequently complicates clinical management[83].

Barrett’s esophagus and neoplasia detection

Barrett’s esophagus surveillance represents an ideal application for Artificial Wisdom, given the challenge of detecting subtle dysplastic changes across extensive mucosal surfaces[84,85]. AI systems could guide systematic inspection protocols while highlighting areas requiring targeted biopsy, potentially improving the yield of surveillance endoscopy[86].

Integration with advanced imaging modalities such as volumetric laser endomicroscopy or optical coherence tomography could provide subsurface tissue characterization, enabling more precise delineation of dysplastic areas and treatment planning[87]. The system could also incorporate patient risk factors and biomarkers to personalize surveillance intervals and ablation candidacy decisions[88,89].

Pancreaticobiliary diagnostics

EUS and endoscopic retrograde cholangiopancreatography represent complex procedures where AI assistance could significantly enhance diagnostic accuracy[90,91]. Artificial Wisdom systems could integrate EUS imaging features with clinical presentation, laboratory values, and cross-sectional imaging to guide tissue sampling decisions[92,93]. For pancreatic cystic lesions, AI systems could incorporate morphological features, cyst fluid analysis, and patient demographics to provide more accurate risk stratification than current guidelines allow[94]. This integrated approach could reduce unnecessary surveillance while ensuring appropriate surgical referral for high-risk lesions.

IMPLEMENTATION CHALLENGES AND GOVERNANCE CONSIDERATIONS

Data quality and standardization

The success of Artificial Wisdom systems depends fundamentally on high-quality, standardized data collection protocols[95]. Current endoscopic databases often lack standardized terminology, consistent image quality, and comprehensive clinical annotation[96,97]. Developing robust data standards and ensuring interoperability across institutions and platforms represents a critical infrastructure requirement[98].

Multicenter validation studies are essential to demonstrate generalizability across diverse patient populations and practice settings[99]. However, such studies require substantial coordination and standardization efforts that may be challenging to implement[100].

Bias mitigation and health equity

AI systems trained on non-representative datasets may perpetuate or amplify existing healthcare disparities, potentially leading to suboptimal care for underrepresented populations[101]. The risk of algorithmic bias is particularly concerning in gastroenterology, where access to advanced endoscopic procedures and screening programs varies significantly across socioeconomic and racial groups. Systematic assessment of model performance across demographic strata, including age, sex, race, ethnicity, and socioeconomic status, is essential to ensure equitable outcomes. This requires deliberate efforts to include diverse populations in training datasets, with careful attention to balancing representation across all relevant demographic categories, and ongoing monitoring of real-world performance across different patient groups to detect any emerging disparities in diagnostic accuracy or clinical recommendations[102]. Transparency in reporting the demographic composition of training and validation datasets is crucial for evaluating the generalizability of AI models.

Geographic and institutional variations in practice patterns, patient populations, disease prevalence, and endoscopic techniques must be considered when deploying AI systems across different clinical settings[103]. Systems that perform well in academic medical centers, where they are often developed and initially validated, may demonstrate reduced accuracy in community practice settings with different patient demographics, case mix complexity, equipment specifications, and operator experience levels. The phenomenon of dataset shift-where the statistical properties of data encountered in real-world deployment differ from those in the training environment—can significantly impact model performance and clinical utility. Institutions implementing AI systems should conduct local validation studies and establish continuous quality monitoring protocols to ensure maintained performance in their specific clinical context.

Regulatory pathways and workflow considerations

The regulatory landscape for AI-enabled medical devices continues to evolve, with agencies like the Food and Drug Administration developing new frameworks for software as medical devices[104,105]. Endoscopic AI systems must navigate complex regulatory requirements while demonstrating safety, efficacy, and clinical utility through rigorous validation studies[106]. Post-market surveillance becomes particularly important for AI systems that continue learning from real-world data. Regulatory frameworks must balance innovation with patient safety while ensuring transparency and accountability in AI-assisted clinical decisions.

Successful implementation of Artificial Wisdom systems requires careful attention to clinical workflow integration[107]. Systems that disrupt established workflows or increase cognitive burden are unlikely to achieve widespread adoption. User interface design, alert fatigue prevention, and seamless integration with existing documentation systems represent critical success factors[108]. Training and education programs must prepare clinicians to effectively utilize AI-assisted decision support while maintaining appropriate clinical judgment[109]. This includes understanding system limitations, interpreting uncertainty estimates, and knowing when to override AI recommendations[110].

FUTURE DIRECTIONS AND RESEARCH PRIORITIES

Causally-informed AI systems

Next-generation Artificial Wisdom systems should incorporate mechanistic understanding of disease processes rather than relying solely on pattern recognition[111]. Causal inference methods could enable more robust predictions and better handling of novel scenarios not represented in training data[112]. Integration of genomic data, microbiome analysis, and molecular biomarkers with endoscopic findings could provide deeper insights into disease mechanisms and treatment responses[113,114]. This multi-omics approach could enable truly personalized diagnostic and therapeutic recommendations[115].

Human-AI collaboration frameworks

Research into optimal human-AI collaboration patterns is essential for maximizing the benefits of Artificial Wisdom systems. This includes understanding when AI assistance is most valuable, how to present information to support rather than replace clinical reasoning, and how to maintain appropriate human oversight. Studies of cognitive ergonomics and decision-making psychology in AI-assisted endoscopy could inform system design and training protocols[116]. Understanding how clinicians integrate AI recommendations with their own observations and judgment is crucial for optimizing outcomes.

Prospective clinical validation

While retrospective studies have demonstrated impressive accuracy metrics for endoscopic AI systems, prospective randomized controlled trials are needed to validate real-world clinical benefits[117,118]. These studies should focus on patient-centered outcomes such as diagnostic accuracy, procedure efficiency, complication rates, and long-term clinical outcomes[119]. Health economic analyses are needed to demonstrate the value proposition of Artificial Wisdom systems, considering not only direct costs but also downstream effects on healthcare utilization, quality of life, and clinical outcomes[120,121].

Ethical frameworks and patient engagement

Development of ethical frameworks for AI-assisted healthcare must address issues of transparency, consent, and patient autonomy. Patients should understand when AI systems influence their care and have the right to opt-out if desired[122]. Patient-reported outcome measures and quality of life assessments should be incorporated into AI system evaluation to ensure that technological advances translate into meaningful improvements in patient experience and outcomes[123].

CONCLUSION

Artificial Wisdom represents a paradigm shift from narrow AI applications toward integrated, translational reasoning systems that combine pattern recognition with causal inference, uncertainty quantification, and patient-centered decision support. In GI endoscopy, this approach offers unprecedented opportunities to enhance diagnostic accuracy, improve workflow efficiency, and standardize care quality while maintaining the human expertise that remains central to clinical medicine.

The successful implementation of Artificial Wisdom in endoscopy requires addressing significant challenges including data standardization, bias mitigation, regulatory compliance, and workflow integration. However, the potential benefits-improved diagnostic consistency, enhanced detection of subtle lesions, personalized risk stratification, and more efficient healthcare delivery-justify substantial investment in research and development.

As we advance toward this future, endoscopy serves as an ideal proving ground for translational reasoning systems, offering real-time decision-making scenarios, rich multimodal data, and clear clinical endpoints for validation studies. The lessons learned from endoscopic applications will undoubtedly inform the broader development of Artificial Wisdom across medical specialties, establishing principles for human-AI collaboration that prioritize patient safety, clinical utility, and healthcare equity.

The next decade will be critical for realizing the promise of Artificial Wisdom in GI diagnostics. Success will require unprecedented collaboration between clinicians, computer scientists, regulatory bodies, and patients to ensure that technological advances translate into meaningful improvements in patient care. By embracing this challenge, the gastroenterology community have the opportunity to lead the transformation of medical practice through intelligent, compassionate, and scientifically rigorous integration of AI with human expertise.